NCT07333612招募中不适用
Comparison of Immunoblotting Bands Pattern in Patients With Treated Versus Untreated Inactive Echinococcal Cysts of the Liver
Fondazione IRCCS Policlinico San Matteo di Pavia1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年9月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Percentage of patients with spontaneously inactivated hepatic CE cysts with positive WB and RT t differente times from diagnosis.
研究概览
简要总结
Comparison of immunoblotting bands pattern in patients with treated versus untreated echinococcal cysts of the liver
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Only Hepatic echinococcal cysts
- •Age > 18 years
- •At leat 2 clinical evaluation
排除标准
- •different location of echinococcal cysts
- •Age < 18 years --less then 2 clinical evalutation
结局指标
主要结局
Percentage of patients with spontaneously inactivated hepatic CE cysts with positive WB and RT t differente times from diagnosis.
时间窗: from September 2024 to September 2026
from 0 to 100%
次要结局
- Percentage of cysts that remaine inactive after treatment or reactivate(from september 2024 to September 2026)
- Percentage of patients with inactivated cysts after treatment with positive WB results at different time point from the first observation of an inactive stage.(from September 2024 to September 2026)
研究者
Raffaella Lissandrin
Principal Investigator
Fondazione IRCCS Policlinico San Matteo di Pavia
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Efferon LPS Hemoadsorption in Patients With Acute PancreatitisNCT07267169Efferon JSC150
招募中
2 期
Study on efficacy of nintedanib for treatment of epistaxis in hereditary haemorrhagic telangiectasia (HHT) patients - EPISTOP2024-518886-89-00Hospices Civils De Lyon20
招募中
3 期
Study aiming to compare the survival of patients with locally advanced or metastatic MSI/dMMR Esogastric adenocarcinomas treated by a combination of Immune checkpoint inhibitors (botensilimab + balstilimab) versus the standard of care (FOLFOX/XELOX + nivolumab)2023-506291-28-00Centre Leon Berard124
招募中
3 期
TAILORED-PROM: Personalized therapeutic approach for preterm premature rupture of membranes to safely prolong pregnancy, enhance maternal and neonatal outcomes, and minimize unnecessary antibiotic use.2024-520237-77-00Vseobecna Fakultni Nemocnice V Praze138
招募中
2 期
A phase 2 open label study of caBozantinib in patients with advanced or unresectable Renal cEll cArcinoma pretreated with one immunochecKPOint INhibiTor (anti PD1/PDL1).2024-514058-59-00Fondazione IRCCS Istituto Nazionale Dei Tumori49